Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance
Guide | 2015
les guides de pratique clinique, les services enveloppants
Guidelines | 2022
Withdrawal, Clinical guidance, Harm reduction, About prescribers
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Substitution/OAT, Carries/take-home doses
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Substitution/OAT, Carries/take-home doses, Illegal drugs
Guidelines | 2022
Clinical guidance, Policy/Regulatory, About prescribers, Harm reduction, Safer supply, Carries/take-home doses, Substitution/OAT
Guidelines | 2022
Clinical guidance, Carries/take-home doses, Policy/Regulatory
Guidelines | 2019
Clinical guidance, About prescribers, Injecting drugs, Safer supply
Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs
Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers
Guidelines | 2021
Withdrawal, Clinical guidance, About prescribers
Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs
To present the 2021 update of the Wound Bed Preparation paradigm
Guidelines | 2021
Clinical guidance, Wrap-around services, About prescribers, Chronic pain, Injecting drugs
Guidelines | 2020
Clinical guidance, Harm reduction, Safer supply, About prescribers, Substitution/OAT, Transitions in care/treatment
Guidelines | 2020
Clinical guidance, About pharmacists, About prescribers
Pharmacists Guidelines for risk mitigation in BC from Vancouver Coastal Health
Guidelines | 2020
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About pharmacists, Stimulants, Substitution/OAT, Injecting drugs
Prescriber Guidelines for risk mitigation in BC from Vancouver Coastal Health
Guidelines | 2020
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Injecting drugs
Guidelines | 2021
Clinical guidance, About prescribers, Chronic pain
Provide clinical guidance to ensure the uninterrupted access to OAT medications for patients during the COVID-19 pandemic.
Guidelines | 2020
Clinical guidance, Harm reduction, About pharmacists, About prescribers
This program guide was developed based on our experiences at two Toronto-based community health centres developing Satellite site programming out of the homes of people who use drugs.
Guidelines | 2020
Overdose, Harm reduction, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Barriers and enablers, Peer/PWLLE program involvement
